← All startups
Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.
Team29
NameLocationLinksContact
Marc Dunoyer
Chief Executive Officer
—
—
Sean Christie
Chief Financial and Administration Officer
—
—
Fred Chereau
SVP Strategy Business Development
—
—
Sarah Marshall
VP
—
—
Scott Weintraub
SVP United States Business Alexion
—
—
Soraya Bekkali
SVP Commercial International
—
—
Aidan Cronolly
Associate Director
—
—
Andreas Rummelt
Director
—
—
Beatriz Romero Rubiols
Medical Director Iberia
—
—
Cho Yoonjoo
Representative Director
—
—
Christiane Denzel
Head Country Operations
Amsterdam, North Holland, Netherlands
—
Christopher J. Coughlin
Director
—
—
Felix J. Baker
Director
—
—
Feng Yang
Senior Director
Tarrytown, New York, United States
—
John T. Mollen
Director
—
—
Jonathan Lu
Executive Director
—
—
Judith A. Reinsdorf
Director
—
—
Julio Hasquiry
Executive Director
—
—
Paul A. Friedman
Director
—
—
Randy Taylor
Director US Strategic Accounts
Ocala, Florida, United States
—
Stefany Ratkovic
Associate Director
Toronto, Ontario, Canada
—
Suzan Caron
Country Director
—
—
Wolfgang Dutzi
Regional Account Manager
Vienna, Vienna, Austria
—
Joy Wang
Principal Scientist
Boston, Massachusetts, United States
—
Craig Wakeford
Meta HEOR
Greater Boston
—
David R. Brennan
Chairman
—
—
Jacqi Kernaghan
Speakers Bureau
West Chester, Pennsylvania, United States
—
Katiria Flores
Scientist III
New York City Metropolitan Area
—
Sumeet Duggal
Marketing Intern
Toronto, Ontario, Canada
—